Clinical features, management, and outcomes of pulmonary mucormycosis: a decade-long retrospective study from a single center in central China - Takeaways - MDSpire

Clinical features, management, and outcomes of pulmonary mucormycosis: a decade-long retrospective study from a single center in central China

  • By

  • Chengqing Yang

  • Chunlin Mei

  • Tanze Cao

  • Minhui Mei

  • Shufang Chen

  • Xiuping Liu

  • Chao Quan

  • Xuan Wang

  • June 11, 2026

  • 0 min

Share

  • 1

    Pulmonary mucormycosis is a severe fungal infection with a high mortality rate, often affecting immunocompromised patients, particularly those with diabetes.

  • 2

    The study analyzed 16 patients, revealing common symptoms such as cough, fever, and chest pain, with bronchial involvement in 68.75% of cases.

  • 3

    Histopathology confirmed the diagnosis in 12 patients, while others were classified as probable cases based on clinical and imaging findings.

  • 4

    Combination therapy, including systemic antifungals and bronchoscopic debridement, was associated with favorable outcomes, with a 12-month survival rate of 81.25%.

  • 5

    Early diagnosis and treatment are critical, as pulmonary mucormycosis often presents with nonspecific symptoms that can lead to delays in care.

Original Source(s)

Clinical features, management, and outcomes of pulmonary mucormycosis: a decade-long retrospective study from a single center in central China

  • by Chengqing Yang, Chunlin Mei, Tanze Cao, Minhui Mei, Shufang Chen, Xiuping Liu, Chao Quan, Xuan Wang

  • June 11, 2026

Related Content

Removal of CD5 on T cells alters their differentiation and cytokine production in an in vitro model investigating effects of P. gingivalis LPS on oral epithelial and immune cells

Origins of CD8 tissue resident memory

Acupuncture for Neuroinfections?

A recent Perspective offered a speculative mechanistic argument for acupuncture’s potential role as an adjunctive strategy in neuroinfectious diseases.